RE: RNS - Halted17 Mar 2022 07:38
The RNS doesn't sound too bad from here?
"Due to these changes in the pandemic, a new clinical trial design is needed to evaluate the efficacy of SNG001 against COVID-19. As a result, lead investigators from ACTIV-2 and Synairgen are in ongoing discussions to try to identify an appropriate clinical trial to continue the evaluation of SNG001."
I get that this means more time until a potential success, but all is not lost?